The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on Doripenem

@article{Mazzei2010ThePA,
  title={The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on Doripenem},
  author={Teresita Mazzei},
  journal={Journal of Chemotherapy},
  year={2010},
  volume={22},
  pages={219 - 225}
}
  • T. Mazzei
  • Published 1 August 2010
  • Biology, Medicine
  • Journal of Chemotherapy
Abstract Carbapenems are the most potent group of beta-lactam agents, having a broad spectrum of bactericidal activity against both Gram-negative and Gram-positive bacteria including anaerobes. Doripenem is a new carbapenem endowed with excellent bactericidal activity, a wide spectrum of antibacterial activity against difficult nosocomial pathogens, including extended-spectrum beta-lactamase producers. Its high stability in solution render it extremely flexible for dosing and infusion time. It… 
11 Citations

Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans

It is suggested that carbapenems andcarbapenem plus amikacin induce substantial increases in the murine intestinal concentration of C. albicans.

Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.

A critical appraisal of newer BL-BLIs has been presented to identify the appropriate clinical situations for their use to ensure clinical efficacy coupled with minimal resistance selection, so that the therapeutic utility of newer agents is preserved for long in light of dwindling global antibiotics pipeline.

Pharmacokinetics of Single‐Dose Doripenem in Adults With Cystic Fibrosis

The pharmacokinetics of doripenem in adult patients with CF are similar to those from adult HVs, noting some differences in the disposition when comparing body mass index‐adjusted pharmacokinetic parameters.

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations

The study showed linearity relationships in the peak plasma concentration and the area under the concentration-time curve after intravenous infusion of doripenem from 0.25 to 1.0 g, which showed linear pharmacokinetics.

Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.

  • A. M. Vilay
  • Medicine, Biology
    Advances in chronic kidney disease
  • 2019
Antibiotic-dosing recommendations should be carefully evaluated considering the accuracy of the renal function assessment, the similarity of the operating characteristics of the kidney replacement therapy studied compared with those being used, and whether the dosing strategy takes advantage of the pharmacodynamic profile of the antibiotic under consideration.

A Novel Reverse Phase HPLC Method for the Quantification of Potential Genotoxic Impurities in Doripenem Monohydrate: A Broad-Spectrum Carbapenem Antibiotic Drug

A novel sensitive gradient reverse phase high performance liquid chromatographic (RP-HPLC) method has been developed and validated for the quantification of potential genotoxic impurities in

Synthesis of unsymmetrical sulfamides and polysulfamides via SuFEx click chemistry†

As hydrogen-bond donors and acceptors, N,N′-disubstituted sulfamides have been used in a range of applications from medicinal chemistry to anion-binding catalysis. However, compared to ureas or

An Apparent Binary Choice in Biochemistry: Mutual Reactivity Implies Life Chooses Thiols or Nitrogen-Sulfur Bonds, but Not Both.

A hypothesis is presented that the N-S bond chemistry is incompatible with essential segments of biochemistry, specifically with thiols, and this work provides an example of a reason why life nearly excludes a distinct region of chemical space.

Carbapenems

References

SHOWING 1-10 OF 79 REFERENCES

Parenteral carbapenems.

  • P. Shah
  • Biology, Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2008
Their in-vitro activity includes extended-spectrum beta-lactamase (ESBL)-producing pathogens and carbapenems are currently considered to be the treatment of choice for serious infections due to ESBL-producing organisms, however, isolates acquiring resistance under treatment have been reported.

The pharmacodynamics of beta-lactams.

  • J. Turnidge
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 1998
With use of time above MIC as the predictor of efficacy, it is possible to reexamine current dosing schedules critically and significantly better outcomes were achieved with continuous infusion against susceptible bacteria or for patients with persistent, profound neutropenia.

Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides.

  • A. MacGowan
  • Biology, Medicine
    Therapeutic drug monitoring
  • 1998
Therapeutic drug monitoring of glycopeptide antibacterial drugs remains controversial, but advances in understanding of their pharmacodynamics and further clinical studies are helping clarify the situation.

The Pharmacodynamics of β-Lactams

With use of time above MIC as the predictor of efficacy, it is possible to reexamine current dosing schedules critically and significantly better outcomes were achieved with continuous infusion against susceptible bacteria or for patients with persistent, profound neutropenia.

Carbapenems: a potent class of antibiotics

  • D. Nicolau
  • Biology, Medicine
    Expert opinion on pharmacotherapy
  • 2008
Doripenem is an investigational carbapenem that has completed Phase III clinical trials and that has the potential to improve on this efficacy and minimize the emergence of resistance to the carbAPenem class.

Comparative Review of the Carbapenems

The unique antimicrobial spectrum and pharmacokinetic properties of ertapenem make it more suited to treatment of community-acquired infections and outpatient intravenous antimicrobial therapy than for the treatment of nosocomial infections.

Two decades of imipenem therapy.

The factors that continue to make imipenem as appropriate an agent for de-escalation therapy now as it was 20 years ago are reviewed.

Pharmacokinetics and pharmacodynamics of antimicrobials.

  • G. Drusano
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007
The rate of discovery of new antibiotics has been declining, coincident with the explosion in the number of multidrug-resistant organisms in both the community and hospital environments, which makes the identification of optimal regimens that will result in good clinical and microbiological outcomes important.
...